We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Flex
FLEX
$41.7B
| $111K | ﹤0.01% |
+15,806
| New | +$102K |
|
|
MFA
827
MFA Financial
MFA
$926M
| $108K | ﹤0.01% |
3,459
-1,238
| -26% | -$37.3K |
|
828
MidCap Financial Investment
MFIC
$787M
| $100K | ﹤0.01% |
4,002
-4,898
| -55% | -$126K |
|
|
ATML
829
DELISTED
ATMEL CORP
ATML
| $100K | ﹤0.01% |
+11,955
| New | +$98.1K |
|
|
WINT
830
DELISTED
Windtree Therapeutics Inc
WINT
| $95K | ﹤0.01% |
+3,134
| New | +$105K |
|
|
EQC
831
DELISTED
Equity Commonwealth
EQC
| $89K | ﹤0.01% |
+3,360
| New | +$85.9K |
|
|
MWW
832
DELISTED
Monster Worldwide Inc
MWW
| $76K | ﹤0.01% |
+10,061
| New | +$72.7K |
|
833
Advanced Micro Devices
AMD
$776B
| $70K | ﹤0.01% |
17,260
-93,440
| -84% | -$357K |
|
|
XOMA
834
DELISTED
Xoma
XOMA
| $58K | ﹤0.01% |
+553
| New | +$80.3K |
|
|
NIHD
835
DELISTED
NII HOLDINGS INC CL B
NIHD
| $51K | ﹤0.01% |
42,680
-920
| -2% | -$2.04K |
|
|
CIM
836
Chimera Investment
CIM
$1.04B
| $45K | ﹤0.01% |
+969
| New | +$45.1K |
|
|
FRED
837
DELISTED
Fred's Inc
FRED
| $26K | ﹤0.01% |
+1,368
| New | +$25.3K |
|
838
Ambev
ABEV
$48.1B
| – | – |
-29,252
| Closed | -$215K |
|
839
Adobe
ADBE
$99.5B
| – | – |
-4,200
| Closed | -$251K |
|
840
Adams Diversified Equity Fund
ADX
$3.13B
| – | – |
-32,389
| Closed | -$424K |
|
841
American Eagle Outfitters
AEO
$2.88B
| – | – |
-13,002
| Closed | -$187K |
|
842
Alamos Gold
AGI
$11.6B
| – | – |
-12,346
| Closed | -$150K |
|
843
Agios Pharmaceuticals
AGIO
$1.79B
| – | – |
-35,000
| Closed | -$838K |
|
|
AIV
844
Aimco
AIV
$387M
| – | – |
-70,917
| Closed | -$245K |
|
845
CALL
Assurant
AIZ
$13.8B
| – | – |
-200
| Closed | -$62K |
|
846
Albemarle
ALB
$13.9B
| – | – |
-5,352
| Closed | -$339K |
|
847
Amgen
AMGN
$208B
| – | – |
-67,806
| Closed | -$7.74M |
|
848
AutoNation
AN
$7.11B
| – | – |
-13,448
| Closed | -$668K |
|
849
Andersons Inc
ANDE
$2.41B
| – | – |
-3,605
| Closed | -$214K |
|
|
AOD
850
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
| – | – |
-133,194
| Closed | -$1.12M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.